You have 9 free searches left this month | to do more

liraglutide

Liraglutide is a drug used to treat Diabetes, Diabetes Mellitus, Type 2, Obesity, and other conditions. Liraglutide is being actively studied in 36 studies and prior, has been studied in 209.

Top SponsorsTop SitesTop Investigators
Novo Nordisk A/SNovo Nordisk Investigational SiteAndrej Janez
Eli Lilly and CompanyUniversity Medical Center LjubljanaParesh Dandona
Hvidovre University HospitalXiangya Hospital of Central South UniversityPeter Rossing
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
X
Withdrawn
  • Obesity
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
2021-04-08
Apr 8, 2021
U
Active, not recruiting
  • Type 1 Diabetes
  • Liraglutide
  • Buffalo, New York
    UBMD Pediatrics, Division of Pediatric Endocrinology
2021-07-28
Jul 28, 2021
M
Completed
  • Diabetes Mellitus, Type II
  • Asheville, North Carolina
    Mountain Diabetes and Endocrine Center
2021-02-23
Feb 23, 2021
M
Completed
  • Obesity
  • Liraglutide
  • Placebo
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-09-17
Sep 17, 2021
C
Active, not recruiting
  • Type 2 Diabetes Treated With Insulin
  • +2 more
  • Lahore, Punjab, Pakistan
    Zainab Khan
2021-04-01
Apr 1, 2021
N
Enrolling by invitation
  • Obesity
  • Overweight
  • Liraglutide
  • Soeborg, Denmark
    Novo Nordisk Investigational Site
2021-04-27
Apr 27, 2021
P
Completed
  • Type 1 Diabetes
  • Liraglutide
  • Placebo for liraglutide
  • Uppsala, Sweden
    Uppsala University Hospital
2020-11-04
Nov 4, 2020
E
Recruiting
  • Obesity
  • Status Post Sleeve Gastrectomy
  • Liraglutide
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-10-02
Oct 2, 2021
Y
Recruiting
  • Obesity, Childhood
  • Neural Development
  • Liraglutide
  • New Haven, Connecticut
    Yale University
2020-12-09
Dec 9, 2020
B
Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Aarhus, Denmark
    Department of Clinical Epidemiology - Aarhus Unversiteteshospita
2021-10-04
Oct 4, 2021
T
Active, not recruiting
  • Type 2 Diabetes
  • Liraglutide
  • Philadelphia, Pennsylvania
    Temple University Hospital
2020-10-19
Oct 19, 2020
C
Active, not recruiting
  • Parkinson Disease
  • Liraglutide
  • Placebo
  • Los Angeles, California
    Cedars Sinai Medical Center
2020-10-22
Oct 22, 2020
U
Recruiting
  • Type 2 Diabetes
  • Peripheral Arterial Disease
  • Liraglutide
  • Control
  • Napoli, Italy
    Unit of Endocrinology and Metabolic Diseases and Unit of Diabete
2021-06-09
Jun 9, 2021
S
Recruiting
  • Type1 Diabetes Mellitus
  • Autoimmune Diabetes
  • Liraglutide
  • +2 more
  • Changsha, Hunan, China
    Institute of Metabolism and Endocrinology, Second Xiangya Hospit
2021-03-24
Mar 24, 2021
U
Recruiting
  • Atrial Fibrillation
  • Liraglutide
  • +3 more
  • Miami, Florida
    University of Miami
2021-05-03
May 3, 2021
H
Completed
  • Diabetes Mellitus, Type 1
  • Liraglutide
  • Placebo
  • Hvidovre, Capital, Denmark
    Dep. of Endocrinology, Hvidovre University Hospital
2021-03-28
Mar 28, 2021
S
Recruiting
  • Obese
  • Overweight
  • Liraglutide
  • Placebo
  • Shanghai, China
    Zhongshan Hosital, Fudan University
2020-11-02
Nov 2, 2020
F
Recruiting
  • Ischemic Stroke
  • +2 more
  • Liraglutide
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Jinan University
2021-02-08
Feb 8, 2021
R
Recruiting
  • Smoking Cessation
  • Weight, Body
  • Liraglutide
  • +2 more
  • Philadelphia, Pennsylvania
    Center for Interdisciplinary Research on Nicotine Addiction, Uni
2021-04-21
Apr 21, 2021
R
Completed
  • Diabetes Mellitus Type 2
  • +3 more
  • Liraglutide
  • Placebo
  • Copenhagen Ø, Denmark
    The department of cardiology, Rigshospitalet Denmark
2021-01-13
Jan 13, 2021
X
Recruiting
  • Obesity
  • Liraglutide
  • placebo
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
2020-08-23
Aug 23, 2020
C
Recruiting
  • Type 1 Diabetes Mellitus
  • Idaho Falls, Idaho
  • +1 more
2021-07-20
Jul 20, 2021
U
Completed
  • Obesity, Visceral
  • +2 more
  • Liraglutide
  • Placebo
  • Dallas, Texas
    University of Texas Southwestern Medical Center
2020-12-20
Dec 20, 2020
C
Completed
  • Pulmonary Disease, Chronic Obstructive
  • Liraglutide
  • Placebo
  • Esbjerg, Denmark
  • +1 more
2021-03-12
Mar 12, 2021
G
Recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • Liraglutide
  • Paris, Groupe Hospitalier Paris Saint-Joseph, France
  • +3 more
2021-03-18
Mar 18, 2021